NASDAQ · Healthcare · Biotechnology
Quoin Pharmaceuticals, Ltd.
QNRX
Quoin Pharmaceuticals, Ltd. CEO Michael Myers · Market cap $9.4M.
$4.70
-0.02 · -0.42%
52w hi $41.8052w lo $3.25
Off 52w high 84.4%
84
STRONG
Current InsiderScore
Corp · 90d
4
4 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
5
3 strong · 2 notable
Analyst consensus
Strong Buy
—
Section 01
Recent Form 4 filings
5 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Aug 31 | Anthony James Culverwell | Buy | 6,146 | $4.88 | +$30K | 66 | |
| Aug 31 | Sally Bridget Lawlor | Chief Financial Officer | Buy | 10,244 | $4.88 | +$50K | 79 |
| Aug 31 | Denise P. Carter | Chief Operating Officer | Buy | 20,490 | $4.88 | +$100K | 81 |
| Aug 31 | Michael Myers | Chief Executive Officer | Buy | 20,490 | $4.88 | +$100K | 84 |
| Oct 14 | Dennis Langer | Buy | 15,152 | $8.49 | +$129K | 63 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
NovDecJanFebMarAprMayJunJulAugSepOct